Abstract:【Abstract】Objective To investigate the effect and mechanism of miR2245p on proliferation and apoptosis of diffuse large Bcell lymphoma cells. Methods The expression of miR2245p and SMAD5 mRNA in diffuse large Bcell lymphoma tissues and cells was detected by RTqPCR. The plasmids miRNC, miR12245p mimic, miR2245p inhibitor, and pcSMAD5 were transfected into U2932 cells separately or in combination by Lipofectamine 2000. Cell growth was detected by MTT method. Cell proliferation was detected by clone formation experiments. Apoptosis was detected by flow cytometry. The relative expression levels of cleaved caspase3, Bax, Bcl2, and SMAD5 proteins were detected by Western blotting. Targeting relationships were detected by a dual luciferase report. Results miR2245p was significantly downregulated in diffuse large Bcell lymphoma tissues and cells. Compared with the control group, the absorbance of U2932 cells and the number of cloned cells in the miR2245p mimic group were significantly reduced, the apoptotic rate and the expression of cleaved Caspase3, Bax, and Bcl2 were significantly reduced (P<001 ). Compared with the control group, the miR2245p inhibitor group significantly increased the absorbance of U2932 cells and the number of cloned cells, the apoptosis rate and the expression of cleaved Caspase3, Bax, and Bcl2 significantly increased (P<001). miR2245p targeted downregulation of SMAD5. Cotransfection of pcSMAD5 reversed the effects of miR2245p on proliferation and apoptosis of diffuse large Bcell lymphoma cells. Conclusion miR2245p overexpression targets SMAD5 and inhibits proliferation and induces apoptosis of diffuse large Bcell lymphoma U2932 cells.